查詢結果分析
來源資料
相關文獻
- 嬰兒型肝臟血管內皮瘤
- Epithelioid Hemangioendothelioma of the Liver: Report of a Case
- Hepatic Hemangioendothelioma in Children: Analysis of Thirteen Cases
- Infantile Hepatic Hemangioendothelioma Presenting as Early Heart Failure: Report of Two Cases
- Epithelioid Hemangioendothelioma of the Liver: CT Findings
- 照顧一位因肝惡性血管內皮瘤接受活體肝臟移植術後之護理經驗
- cDNA Cloning and Expression Analysis of the Human UDPglucose Dehydrogenase
- Flutamide-Induced Liver Injury: A Case Report
- 二氧化碳顯影電腦斷層與二氧化碳顯影超音波於肝臟腫瘤之比較
- Mesenchymal Hamartoma of the Liver: A Case Report
頁籤選單縮合
題 名 | Hepatic Hemangioendothelioma in Children: Analysis of Thirteen Cases=兒童期之肝臟血管內皮瘤:十三病例分析 |
---|---|
作 者 | 陳建彰; 江文山; 楊兆平; 洪悠紀; | 書刊名 | 臺灣兒科醫學會雜誌 |
卷 期 | 44:1 民92.01-02 |
頁 次 | 頁8-13 |
分類號 | 417.5453 |
關鍵詞 | 肝臟; 血管內皮瘤; Hemangioendothelioma; Computed tomography; Magnetic resonance imaging; Steroids; Interferon; |
語 文 | 英文(English) |
中文摘要 | 肝臟血管內皮瘤是好發於在嬰兒及兒期之腫瘤。從1986至2001年,共有13位罹患肝臟血管內皮瘤的兒童(9例男性,4例女性)在本院診斷治療。其中1位的年齡均小於六個月,而僅有一位在診斷時已達兩歲。在這13位病童中,10位病童有臨床症狀,而大部分需要治療的原因乃由於血小板過低、貧血、心衰竭、呼吸窘迫、或是黃疸。有一位病童接受部份肝臟切除手術,另外一位則接受肝動脉栓塞治療。計有7例病童接受類固醇藥物治療,3例病童給予干擾素治療,有一位病童接受化學治療。在這13位病童中,有4位病童僅給予保守療法。本欠的統計,有4例病童不幸死亡,死因是由於敗血症,腫瘤破裂併發出血休克,或是肝臟衰竭。適當的治療,長期的追踪對患有肝臟血管內皮瘤的兒童來說是很重要的。 |
英文摘要 | Hepatic hemangioendothelioma (HE) is a tumor that presents in infancy and toddler. It manifests hepatomegaly, abdominal mass, jaundice, abdominal distention, or high output cardiac failure. We reviewed patients with HE in our hospital in the past 15 years (from July 1986 to June 2001). The diagnosis was made by the histology specimen or various imaging studies. There were thirteen patients (9 males, 4 females) enrolled in our study. Their ages ranged from neonate to 2 years old. The common clinical manifestations included abdominal distention (53%) congestive heartfailure (38.5%), abdominal mass (30.8%), jaundice (30.8%), and skin hemangioma (23.1%). Nine patients had serum alanine aminotransferase examination and were abnormal in 2. Anemia was noted in 7 of 13 (53.8%) patients, thrombocytopenia and hyperconsumptive coagulopathy were found in 4 and 5 patients, respectively. Serum alpha-fetoprotein was elevated in 4 of 7patients. Abdominal ultrasonography (n=13) showed heterogeneous and hypoechoic lesions in the liver. Computed tomography (n=11) revealed central hypointensity with peripheral enhancement after contrast of the liver masses. Magnetic resonance imaging studies of the hepatic masses (n=3) showed decreased signal intensity on Ti images and high signal intensity on T2. Most patients were treated with steroid. Other management included interferon, chemotherapy, embolization and or surgery. Four patients were managed conservatively. Among the other nine patients, four patients died of sepsis, hepatic failure, disseminated intravascular coagulopathy or tumor rupture with hemorrhagic shock. HE appears to be a histologically benign tumor but may have a poor outcome because of complications. For its management, steroid is a first-line medication. Other methods of treatment were interferon, hepatic artery embolization, chemotherapy and surgery. Long term follow up is needed for the evaluation of treatment response. |
本系統中英文摘要資訊取自各篇刊載內容。